Press releases
- Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Geron to Participate at Upcoming Investor Conferences in April
- Geron Corporation Announces Pricing of $150 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
- Geron Announces FDA Oncologic Drugs Advisory Committee Votes in Favor of the Clinical Benefit/Risk Profile of Imetelstat for the Treatment of Transfusion-Dependent Anemia in Patients with Lower-Risk MDS
- Geron Corporation Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
- Geron to Announce Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024
More ▼
Key statistics
As of last trade Geron Corp (0IV3:LSE) traded at 3.76, -6.09% below its 52-week high of 4.01, set on Apr 12, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 3.76 |
Average volume | 4.93k |
---|---|
Shares outstanding | 586.91m |
Free float | 586.40m |
P/E (TTM) | -- |
Market cap | 2.19bn USD |
EPS (TTM) | -0.3246 USD |
Data delayed at least 20 minutes, as of Apr 22 2024 17:53 BST.
More ▼